Increased risk of hospitalization for acute lower respiratory tract infection among australian indigenous infants 5-23 months of age following pneumococcal vaccination: A cohort study

Clinical Infectious Diseases

Volumn 50, Issue 7, 2010, Pages 970-978

  O'Grady, Kerry Ann F ^a   Lee, Katherine J ^b,c   Carlin, John B ^b,c   Torzillo, Paul J ^d,e,i   Chang, Anne B ^a,f   Kim Mulholland, E ^a,j   Lambert, Stephen B ^g,h   Andrews, Ross M ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^f Queensland Children's Respiratory Centre   (Australia)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

^h UNIVERSITY OF QUEENSLAND   (Australia)

ⁱ Anangu Pitjantjatjara Yankunytjatjara   (Australia)

^j LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ACUTE GASTROENTERITIS; ANEMIA; ARTICLE; AUSTRALIA; BACTERIAL PNEUMONIA; BRONCHIOLITIS; BRONCHITIS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HAZARD RATIO; HOSPITALIZATION; HUMAN; INCIDENCE; INDIGENOUS PEOPLE; INFANT; INFECTION RISK; INFLUENZA; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK REDUCTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VIRUS PNEUMONIA;

ACUTE DISEASE; AUSTRALIA; COHORT STUDIES; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMANS; INFANT; MALE; PNEUMOCOCCAL VACCINES; POPULATION GROUPS; PROPORTIONAL HAZARDS MODELS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77749316814     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/651079     Document Type: Article

References (43)

1. Li SQ, Guthridge S, d'Espaignet ET, Paterson B. From infancy to young adulthood: health status in the Northern Territory, 2006. Darwin, Australia: NT Department of Health & Families, 2007.
2. 2. Valery PC, Torzillo PJ, Mulholland K, Boyce NC, Purdie DM, Chang AB. Hospital-based case-control study of bronchiectasis in Indigenous children in Central Australia. Pediatr Infect Dis J 2004; 23(10):902-908. (Pubitemid 40812775)
3. Selvey CE. Conjugate pneumococcal vaccine coverage. Northern Territory Disese Control Bulletin 2001;8(4):29-31.
4. O'Grady K, Carlin JB, Chang AB, et al. 7-Valent pneumococcal conjugate vaccine effectiveness against WHO-defined radiologically diagnosed pneumonia in Indigenous Australian infants. Bull World Health Org 2010;88:139-146.
5. Zhang X, Dempsey K, McNelley S. Northern Territory midwives collection: mothers and babies 2003. Darwin, Australia: Northern Territory Government, 2009.
6. Clucas DB, Carville KS, Connors C, Currie BJ, Carapetis JR, Andrews RM. Disease burden and health-care clinic attendances for young children in remote Aboriginal communities of" northern Australia. Bull World Health Organ 2008;86(4):275-281.
7. Thorman S, Merianos A. Immunisation coverage of children 12-14 months in real time. Northern Territory Communicable Diseases Bulletin 1997;4(4):1-4.
8. Bullen S, Selvey CE. Combined analysis of two ACIR cohorts of NT children aged 12 to <15 months. Northern Territory Communicable Disease Control Bulletin 2002;9(2):19-22.
9. National Centre for Classification in Health. International classification of diseases, 10th revision-Australian modification. 5th ed. Sydney, Australia: University of Sydney, 2006.
10. World Health Organization Pneumonia Vaccine Trial Investigators Group. Standardization of interpretation chest radiographs for the diagnosis of pneumonia in children. Geneva, Switzerland: World Health Organization, 2001.
11. Prentice RL, Williams J, Peterson AV. On the regression analysis of mutivariate failure time data. Biometrika 1982;69:331-342.
12. Efron B. The efficiency of Cox's likelihood function for censored data. J Am Stat Assoc 1977;72:557-565.
13. Bailie RS, Si D, Dowden MC, et al. A systems approach to improving timeliness of immunisation. Vaccine 2009;27(27):3669-3674.
14. O'Grady KA, Krause V, Andrews R. Immunisation coverage in Australian Indigenous children: time to move the goal posts. Vaccine 2009; 27(2):307-312.
15. 15. Skull S, Krause V, Roberts L, Dalton C. Evaluating the potential for opportunistic vaccination in a Northern Territory hospital. J Paediatr Child Health 1999;35(5):472-475. (Pubitemid 29472843)
16. Bailie RS, Si D, Dowden MC, et al. Delivery of child health services in Indigenous communities: implications for the federal government'semergency intervention in the Northern Territory. Med J Aust 2008; 188(10):615-618.
17. De Wals P, Robin E, Fortin E, Thibeault R, Ouakki M, Douville-Fradet M. Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatr Infect Dis J 2008; 27(11);963-968.
18. Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a timeseries analysis. Lancet 2007;369(9568):1179-1186.
19. Nelson JC, Jackson M, Yu O, et al. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine 2008; 26(38);4947-1954.
20. Krause VL, Reid SJ, Medanos A. Invasive pneumococcal disease in the Northern Territory of Australia, 1994-1998. Med J Aust 2000; 173 (Suppl):S27.
21. 21. Burgner D, Richmond P. The burden of pneumonia in children: an Australian perspective. Paediatr Respir Rev 2005;6(2):94-100. (Pubitemid 40692046)
22. 22. Leach AJ, Boswell JB, Asche V, Nienhuys TG, Mathews JD. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian Aboriginal infants. Pediatr Infect Dis J 1994; 13(11);983-989. (Pubitemid 24363108)
23. Leach AJ. Otitis media in Australian Aboriginal children: an overview. Int J Pediatr Otorhinolaryngol 1999;49(Suppl 1):S173-S178.
24. Nuorti JP, Martin SW, Smith PJ, Moran JS, Schwartz B. Uptake of pneumococcal conjugate vaccine among children in the 1998-2002 United States birth cohorts. Am J Prev Med 2008; 34(1):46-53.
25. 25. Singleton RJ, Bruden D, Bulkow LR, Varney G, Butler JC. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season. Pediatr Infect Dis J 2006; 25(12) ;116-1122. (Pubitemid 44900674)
26. Lucero MG, Nohynek H, Williams G, et al. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial. Pediatr Infect Dis J 2009;28(6): 455-462.
27. 27. Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebocontrolled trial. Lancet 2005; 365(9465):1139-1146. (Pubitemid 40417563)
28. Klugman KP, Madhi SA, Heubner R, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003; 349(14): 1341-1348.
29. 29. Destefano F, Pfeifer D, Nohynek H. Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data. Bull World Health Organ 2008;86(5):373-380. (Pubitemid 351694318)
30. O'Brien KL. Pneumococcal vaccine and the dance of the veils. Pediatr Infect Dis J 2009; 28(6):463-1165
31. Roche PW, Krause V, Cook H, et al. Invasive pneumococcal disease in Australia, 2006. Commun Dis Intell 2008;32(1): 18-30.
32. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R. Sitespecific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J 2006;25(7):602-607.
33. 33. Hanage WP, Auranen K, Syrjanen R, et al. Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines. Infect Immun 2004; 72(1):76-81. (Pubitemid 38018163)
34. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 2004; 190(7):1203.
35. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003; 187(9):1424-1432.
36. Mellon G, Leach AJ, Morris PS, et al. Pneumococcal carriage in remote Aboriginal communities in the Northern Territory of Australia, 2003 & 2005 [abstract PO3.47]. In: Program and abstracts of the 5th International Symposium on Pneumococci and Pneumococcal Diseases, Alice Springs, Australia, April 2006. Darwin, Australia: ISPPD, 2006.
37. Russell FM, Carapetis JR, Ballock A, et al. Hyporesponsiveness to rechallenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomised controlled trial. Vaccine (in press).
38. O'Brien KL, Hochman M, Goldblatt D. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? Lancet Infect Dis 2007; 7(9) :597-606.
39. Australian Bureau of Statistics. National Aboriginal and Torres Strait Islander health survey 2004-2005. ABS cat. no.4715.0. Canberra: ABS 2006a.
40. 40. Keren R, Wheeler A, Coffin SE, Zaoutis T, Hodinka R, Heydon K. ICD9 codes for indentifying influenza hospitalizations in children. Emerg Infect Dis 2006; 12(10):1603-1604. (Pubitemid 44570911)
41. 41. van de Garde EM, Oosterheert JJ, Bonten M, Kaplan RC, Leufkens HG. International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia. J Clin Epidemiol 2007; 60(8) :834-838. (Pubitemid 46990803)
42. Guevara RE, Butler JC, Marston BJ, Plouff'e JF, File TM Jr, Breiman RF. Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol 1999;149(3):282-289.
43. 43. Chang AB, Grimwood K, Mulholland EK, Torzillo PJ. Bronchiectasis in Indigenous children in remote Australian communities. Med J Aust 2002; 177(4):200-204. (Pubitemid 35021432)